UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 91

Sortiert nach

Ten-year follow-up of helium ion therapy for uveal melanoma

American journal of ophthalmology, 1998, Vol.125 (1), p.81-89

1998

Link zum Volltext

Verfügbarkeit prüfen

A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis

Journal of rheumatology, 2005-12, Vol.32 (12), p.2345

2005

Link zum Volltext

Verfügbarkeit prüfen

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab

Blood, 2005-06, Vol.105 (12), p.4576-4582

2005

Link zum Volltext

Verfügbarkeit prüfen

131I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma

The New England journal of medicine, 2005-02, Vol.352 (5), p.441-449

2005

Link zum Volltext

Verfügbarkeit prüfen

Abstract B77: Phase I study of TH-302, an investigational hypoxia-targeted drug, in combination with sunitinib

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.B77-B77

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 Study Of TH-302, An Investigational Hypoxia-Targeted Drug, and Dexamethasone In Patients With Relapsed/Refractory Multiple Myeloma

Blood, 2013-11, Vol.122 (21), p.1948-1948

2013

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1 Study Of TH-302, An Investigational Hypoxia-Targeted Drug, In Patients With Advanced Leukemias

Blood, 2013-11, Vol.122 (21), p.3920-3920

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of TH-302, a hypoxia-activated cytotoxic prodrug, in subjects with advanced leukemias

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.6585-6585

2012

Link zum Volltext

Verfügbarkeit prüfen

Orbital metastases: diagnosis and course

British journal of ophthalmology, 1997-05, Vol.81 (5), p.386-390

1997

Link zum Volltext

Verfügbarkeit prüfen

Patient-specific whole-body dosimetry : Principles and a simplified method for clinical implementation

The Journal of nuclear medicine (1978), 1998-08, Vol.39 (8), p.S14-S20

1998

Link zum Volltext

Verfügbarkeit prüfen

Late radiation failures after iodine 125 brachytherapy for uveal melanoma compared with charged-particle (proton or helium ion) therapy

Ophthalmology (Rochester, Minn.), 2002-10, Vol.109 (10), p.1850-1854

2002

Link zum Volltext

Verfügbarkeit prüfen

Abstract B185: Bench to bedside experience with TH-302: A tumor-selective hypoxia-activated prodrug as a promising treatment for prostate cancer

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.B185-B185

2009

Link zum Volltext

Verfügbarkeit prüfen

A practical methodology for patient release after tositumomab and (131)I-tositumomab therapy

The Journal of nuclear medicine (1978), 2002-03, Vol.43 (3), p.354

2002

Link zum Volltext

Verfügbarkeit prüfen

Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma : a prospective, randomized, dynamically balanced trial

Ophthalmology (Rochester, Minn.), 1993-10, Vol.100 (10), p.1547-1554

1993

Link zum Volltext

Verfügbarkeit prüfen

Randomized trial of radiation for age-related macular degeneration

American journal of ophthalmology, 1999-05, Vol.127 (5), p.574-578

1999

Link zum Volltext

Verfügbarkeit prüfen

sup 131^I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma

The New England journal of medicine, 2005-02, Vol.352 (5), p.441

2005

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy for high grade clinically localized adenocarcinoma of the prostate

The Journal of urology, 1996-11, Vol.156 (5), p.1719

1996

Link zum Volltext

Verfügbarkeit prüfen

131 I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma

The New England journal of medicine, 2005-02, Vol.352 (5), p.441-449

2005

Link zum Volltext

Verfügbarkeit prüfen

Tositumomab and Iodine I 131 Tositumomab (The BEXXAR® Therapeutic Regimen) Produced Ongoing, Durable Remissions of More Than 5 Years in 9 Patients with Non-Hodgkin's Lymphoma (NHL) in a Pivotal Study of Patients Refractory to Their Last Chemotherapy

Blood, 2004-11, Vol.104 (11), p.2631-2631

2004

Link zum Volltext

Verfügbarkeit prüfen

A Practical Methodology for Patient Release After Tositumomab and 131I-Tositumomab Therapy

The Journal of nuclear medicine (1978), 2002-03, Vol.43 (3), p.354-363

2002

Link zum Volltext

Verfügbarkeit prüfen

Volume reduction versus radiation dose for tumors in previously untreated lymphoma patients who received iodine‐131 tositumomab therapy

Cancer, 2002-02, Vol.94 (S4), p.1258-1263

2002

Link zum Volltext

Verfügbarkeit prüfen

Five-year follow-up of helium ion therapy for uveal melanoma

Archives of ophthalmology (1960), 1990-02, Vol.108 (2), p.209

1990

Link zum Volltext

Verfügbarkeit prüfen

Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience

Blood, 2000-08, Vol.96 (4), p.1259-1266

2000

Link zum Volltext

Verfügbarkeit prüfen

Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience

Blood, 2000-08, Vol.96 (4), p.1259-1266

2000

Link zum Volltext

Verfügbarkeit prüfen

2107 An analysis of pretreatment characteristics and the risk of PSA failure by race and ethnicity in prostate cancer patients treated with definitive radiotherapy

International journal of radiation oncology, biology, physics, 1997, Vol.39 (2), p.294-294

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 91

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(83)

Publikationsform

Artikel
(89)
Bücher
(1)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ten-year follow-up of helium ion therapy for uveal melanoma

A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab

131I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma

Abstract B77: Phase I study of TH-302, an investigational hypoxia-targeted drug, in combination with sunitinib

Phase 1 Study Of TH-302, An Investigational Hypoxia-Targeted Drug, and Dexamethasone In Patients With Relapsed/Refractory Multiple Myeloma

A Phase 1 Study Of TH-302, An Investigational Hypoxia-Targeted Drug, In Patients With Advanced Leukemias

Phase I study of TH-302, a hypoxia-activated cytotoxic prodrug, in subjects with advanced leukemias

Orbital metastases: diagnosis and course

Patient-specific whole-body dosimetry : Principles and a simplified method for clinical implementation

Late radiation failures after iodine 125 brachytherapy for uveal melanoma compared with charged-particle (proton or helium ion) therapy

Abstract B185: Bench to bedside experience with TH-302: A tumor-selective hypoxia-activated prodrug as a promising treatment for prostate cancer

A practical methodology for patient release after tositumomab and (131)I-tositumomab therapy

Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma : a prospective, randomized, dynamically balanced trial

Randomized trial of radiation for age-related macular degeneration

sup 131^I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma

Radiotherapy for high grade clinically localized adenocarcinoma of the prostate

131 I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma

Tositumomab and Iodine I 131 Tositumomab (The BEXXAR® Therapeutic Regimen) Produced Ongoing, Durable Remissions of More Than 5 Years in 9 Patients with Non-Hodgkin's Lymphoma (NHL) in a Pivotal Study of Patients Refractory to Their Last Chemotherapy

A Practical Methodology for Patient Release After Tositumomab and 131I-Tositumomab Therapy

Volume reduction versus radiation dose for tumors in previously untreated lymphoma patients who received iodine‐131 tositumomab therapy

Five-year follow-up of helium ion therapy for uveal melanoma

Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience

Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience

2107 An analysis of pretreatment characteristics and the risk of PSA failure by race and ethnicity in prostate cancer patients treated with definitive radiotherapy

Aktive Filter

Suchergebnisse filtern